3/3/2006 | BT | Inamed says phase 3 study shows Juvederm superior to Zyplast
|
12/13/2005 | BT | Inamed board recommends shareholders accept Allergan's $3.2 billion merger offer
|
12/13/2005 | BT | Medicis, Inamed terminate merger deal; Inamed pays $90 million fee, clearing way for Allergan offer
|
12/13/2005 | BT | Market Commentary: CuraGen sinks; Indevus soars; Voyager pulls IPO; Insmed up on FDA approval; Tercica falls
|
12/6/2005 | BT | Inamed's board says Allergan's $3.2 billion merger offer tops Medicis offer, but remains neutral
|
11/22/2005 | BT | Medicis wants Inamed to recommend that stockholders reject Allergan's rival merger offer
|
11/21/2005 | BT | Medicis rebuffs Mentor's $2.2 billion merger offer, says it is committed to deal with Inamed
|
11/21/2005 | BT | Market Commentary: Incyte zooms on R&D pact with Pfizer; Medicis, Mentor, Allergan, Inamed tangle in merger scuffle
|
11/16/2005 | BT | Market Commentary: Gilead gains on Roche settlement; AtheroGenics sinks; Amylin rises
|
11/15/2005 | BT | Market Commentary: Allergan bid a wrinkle in Medicis merger with Inamed; Biovail off on spinoff plan; SkyePharma up
|
11/15/2005 | CV | Market Commentary: Ford, GM, oil and gas, airlines down; EDO shows up in the gray; Pantry, C&D, E*Trade deals ahead
|
11/15/2005 | BKBT | S&P places Inamed on positive watch
|
11/15/2005 | BT | Allergan unveils $3.2 billion bid for Inamed, topping Medicis offer by $450 million
|
6/30/2005 | BT | Market Commentary: Elan shares move up, credit lags, Connetics rises against the tide; Medicis, Inamed up; Millipore off
|
4/13/2005 | BK | S&P: Inamed unaffected
|
3/14/2005 | BK | S&P upgrades Inamed
|
6/23/2004 | BK | S&P: Inamed unaffected
|
4/23/2004 | BK | S&P: Inamed unaffected
|
11/24/2003 | BK | S&P affirms Colonial Properties ratings
|
8/20/2003 | BK | S&P puts Krayton Polymers on developing watch
|
6/30/2003 | BK | Inamed $100 million credit facility launches Monday
|
6/2/2003 | BKHY | S&P cuts IMC Global
|